FDA Launches Six-Month Safety Review of Abortion Pill Mifepristone, WSJ Reports

The FDA has started a roughly six-month safety review of the abortion drug mifepristone, the Wall Street Journal reported on June 4. The review will use existing drug-safety systems and is being structured to w...



























